Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2026 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics First Quarter 2026 Business Update Conference Call. Please note that this event is being recorded.
Lucid Diagnostics Inc. (LUCD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Masters Capital Management Mike Masters | 4,000,000 | $4,600,000 | 0.15% | |
| 2. | Two Seas Capital Sina Toussi | 3,000,000 | $3,450,000 | 0.05% | |
| 3. | Renaissance Technologies Jim Simons | 499,661 | $574,610 | -40% | 0% |
| 4. | AQR Capital Management Cliff Asness | 234,769 | $269,984 | +188% | 0% |
| 5. | Squarepoint Ops LLC Maxime Fortin (Cio) | 115,022 | $132,275 | -67% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.02 | 100,000 | $101,840.00 | 665,443 | 2025-08-20 | Filing | |
| $1.32 | 33,218 | $43,794.61 | 565,443 | 2025-05-22 | Filing | |
| $1.32 | 129,684 | $171,520.06 | 532,225 | 2025-05-21 | Filing | |
| $1.30 | 187,098 | $242,291.91 | 402,541 | 2025-05-20 | Filing | |
| $1.32 | 33,218 | $43,794.61 | 350,000 | 2025-05-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.45 | 9,747 | $14,133.15 | 101,592 | 2023-09-26 | Filing | |
| $1.43 | 10,000 | $14,300.00 | 111,339 | 2023-09-26 | Filing | |
| $1.47 | 10,000 | $14,740.00 | 121,339 | 2023-09-26 | Filing | |
| $1.43 | 200 | $286.00 | 131,339 | 2023-09-25 | Filing | |
| $1.44 | 100 | $144.00 | 131,539 | 2023-09-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,638,243 | $5,333,979 | 0% | |
| 2. | 4,154,770 | $4,777,986 | 0% | |
| 3. | 3,644,277 | $4,190,919 | 0.01% | |
| 4. | 2,245,350 | $2,582,785 | 0% | |
| 5. | 1,583,608 | $1,821,147 | 0% |
News See All
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Inc. Fourth Quarter 2025 Business Update Conference Call. At this time, lines are in listen-only mode.
Here's Why Lucid Diagnostics (LUCD) Declined in Q3
Minot Light Capital Partners, an investment management company, released its Q3 2025 investment letter. A copy of the letter can be downloaded here.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Inc. Third Quarter 2025 Business Update Conference Call. Please note this event is being recorded.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Second Quarter 2025 Business Update Conference Call. [Operator Instructions] Please note that this event is being recorded.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Fourth Quarter 2024 Business Update Conference Call. At this time, all lines are in listen-only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Second Quarter 2024 Business Update Conference Call. At this time, all lines are in a listen-only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics First Quarter 2024 Business Update Conference Call. At this time all lines are in listen only mode.
Lucid Diagnostics Inc. (NASDAQ:LUCD) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Lucid Diagnostics Fourth Quarter and Full Year 2023 Business Update Conference Call. [Operator Instructions] Please note this event is being recorded.